Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans
Katsumasa Nakajima(Boston Biomedical Research Institute), Michael H. Serrano‐Wu(Broad Institute), Ricardo E. Chatelain, Cornelia J. Forster(Novartis (United States)), Aaron Kanter, Alan D. Neubert, Paul V. Szklennik, Charles D. Meyers, Thomas Daniels, Vivienne Tedesco, Renee Commerford, Young‐Shin Kwak, Brian K. Hubbard(Broad Institute), Yongjin Gong, Thomas A. Gilmore, David M. Truong(New York University), Qing Yang(Guangzhou University of Chinese Medicine), Jingzhou Li, Monish Jain, James Thompson(University Hospital Southampton NHS Foundation Trust), Gary M. Coppola, Kevin B. Clairmont
Cited by 18
Related Papers
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
Identification of Hepatitis C Virus NS5A Inhibitors
|Journal of Virology|2009|196
Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose
|Journal of Pharmacology and Experimental Therapeutics|2005|87
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes
|ACS Medicinal Chemistry Letters|2011|86